Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Intravenous alpha-1 antitrypsin augmentation therapy: systematic review
Peter C Gøtzsche,
Helle Krogh Johansen
Department of Immunology and Microbiology
10
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Intravenous alpha-1 antitrypsin augmentation therapy: systematic review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Augmentation Therapy
100%
Alpha-1 Antitrypsin
100%
Confidence Interval
75%
Drug Groups
75%
Placebo Groups
75%
Group Differences
50%
Treatment Costs
25%
Forced Expiratory Volume in 1 Second (FEV1)
25%
Clinical Benefit
25%
Lung Density
25%
Mortality Data
25%
Metaanalysis
25%
Deficiency Diseases
25%
PubMed
25%
Quality of Life
25%
Randomized Trial
25%
Lung Disease
25%
Placebo
25%
Carbon Dioxide
25%
First Trial
25%
Absence of Evidence
25%
Alpha-1 Antitrypsin Deficiency
25%
Serious Adverse Events
25%
Computed Tomography
25%
Nursing and Health Professions
Systematic Review
100%
Alpha 1 Antitrypsin
100%
Placebo
100%
Confidence Interval
75%
Computer Assisted Tomography
25%
Carbon Monoxide
25%
Lung Disease
25%
Adverse Event
25%
Meta Analysis
25%
Quality of Life
25%
Alpha 1 Antitrypsin Deficiency
25%
Medline
25%
Forced Expiratory Volume
25%
Medicine and Dentistry
Alpha 1 Antitrypsin
100%
Placebo
100%
Systematic Review
100%
Silo-Filler's Disease
25%
Meta-Analysis
25%
Computer Assisted Tomography
25%
Lung
25%
Quality of Life
25%
Carbon Monoxide
25%
Health Care Cost
25%
Adverse Event
25%
Alpha 1-Antitrypsin Deficiency
25%
Forced Expiratory Volume
25%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Alpha 1 Antitrypsin
100%
Alpha 1 Antitrypsin Deficiency
25%
Adverse Event
25%
Carbon Monoxide
25%
Lung Disease
25%
Immunology and Microbiology
Alpha 1-Antitrypsin
100%
Medline
25%
Forced Expiratory Volume
25%
Computer Assisted Tomography
25%